Gene Therapy for Rare Disorders

The 4th Annual Gene Therapy for Rare Disorders will focus exclusively on overcoming the late-stage commercial challenges drug developers face when delivering gene therapies to market.

Event Information:

Wednesday, February 24, 2021 11:00 am Industrializing Gene Therapies: The Role of Manufacturing Technologies

Clive Glover, Director, Strategy, Cell & Gene Therapy

Synopsis

•  Successful commercialization of gene therapies is dependent on robust, consistent manufacturing methods that are appropriate for the scale required for the targeted indication
• Current manufacturing is often dependent on technologies that cannot be scaled in a series of disconnected unit operations reducing consistency and robustness
  
• This talk will demonstrate the creation of a full end-to-end, scalable platform solution for viral vector manufacturing
  
• This solution can be deployed rapidly allowing therapies to get to market rapidly